Cipher Digital Q1 Results: Mining Losses, But AI Future Pays Off Big
Cipher is shifting from Bitcoin mining to AI data centers, signing $11B deals and betting big on future growth despite current losses.
NOTRELOAD AI
Cytokinetics’ Myqorzo Succeeds Where Camzyos Failed: Positive Phase 3 Results in Non-Obstructive HCM
Cytokinetics’ (aficamten) met both primary endpoints in the Phase 3 ACACIA-HCM trial for non-obstructive hypertrophic cardiomyopathy (nHCM). Already approved for obstructive HCM, the drug could soon double its market.
IREN Buys Mirantis: $625M Deal Boosts AI Infrastructure & Enterprise Support
IREN is buying Mirantis for $625M to boost its AI cloud, making services faster, easier, and more reliable for businesses.
Viridian’s Elegrobart Scores Big Win in Chronic Thyroid Eye Disease Phase 3 Trial – Shares Soar
Viridian's drug for thyroid eye disease showed strong Phase 3 results, improving eye symptoms with simple injections and possible home use.
Q1 Beat for Shopify, But Softer Guidance and Macroeconomic Concerns Weigh on Shares
Despite a record Q1, Shopify forecasts high-20% revenue growth for Q2 2026, below consensus expectations. Operating expenses are set to rise as the company ramps up AI investments.
PayPal’s Strong Q1 2026 Beat Overshadowed by Cautious Q2 Warning as Cost Savings Loom
PayPal beat Q1 estimates on revenue and profit, but Q2 outlook is weak with expected EPS drop as costs rise; full year mixed.